Dr. J. William Harbour is the ocular oncologist who developed DecisionDx-UM, the first and only validated prognostic test for uveal, or ocular, melanoma. The test predicts with a very high degree of accuracy which uveal tumors will likely spread–and thus ultimately prove fatal–and which will not, a valuable tool for guiding clinical treatment.
He has been the principal investigator on major research grants from the National Cancer Institute, National Eye Institute, Melanoma Research Foundation, Melanoma Research Alliance, Research to Prevent Blindness and other foundations. He founded the Collaborative Ocular Oncology Group that conducted the largest multi-center, prospective study ever performed to validate a molecular prognostic test in uveal melanoma. He also founded the Ocular Oncology Research Society and other collaborative initiatives in eye cancer treatment and research.
Dr. Harbour is currently Professor of Ophthalmology, Vice Chairman for Translational Research, and Director of the Ocular Oncology Service at the Bascom Palmer Eye Institute in Miami.
To read exchanges with patients or to ask your own questions about uveal melanoma or the prognostic test, visit Dr. Harbour’s page on the popular blog TalkAboutHealth.com.